BTA biota holdings limited
Add to My Watchlist 0.00% ! 57.0¢

biocryst's last roll of the dice

  1. jessie1
    8,256 Posts.
    clock Created with Sketch.
    08/12/12
    05:48
    Post #: 11163058
    After multiple programs have fallen over, Biocryst is cuting staff and programs in a last ditch effort to stay afloat:

    http://www.bizjournals.com/triangle/news/2012/12/07/biocryst-cutting-work-force-to-save.html?ana=yfcpc

    "Research Triangle Park drug development company BioCryst Pharmaceuticals (Nasdaq: BCRX) is restructuring in a last ditch effort to advance its preclinical candidates – and it’s a move that will cut the company’s head count in half."

    They are still going to persevere with BCX5191.
    BTA Price at posting: 0.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Anson Adds 100 Strategic Claims to Green River Lithium Project
right-arrow Created with Sketch.
VMM Colossus PFS Unlocks World-Class Project Economics and Positions Viridis for Global Leadership
right-arrow Created with Sketch.
NEWS Copper and Base Metals Targets Confirmed at Minbrie with Drilling Ahead
right-arrow Created with Sketch.
NUZ Positive FDA feedback on NUZ-001 strategy to lift clinical hold
right-arrow Created with Sketch.
CC9 Chariot to Acquire Majority Stake in a Nigerian Lithium Portfolio
right-arrow Created with Sketch.
HAR Maiden Drilling Program to Commence at Ibel South Gold Project
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.